Option Care Health (NASDAQ:OPCH) Upgraded at Jefferies Financial Group

Jefferies Financial Group upgraded shares of Option Care Health (NASDAQ:OPCH) from a hold rating to a buy rating in a report released on Thursday, MarketBeat.com reports. The firm currently has $35.00 price target on the stock, up from their previous price target of $26.00.

OPCH has been the subject of several other reports. Truist Financial decreased their price objective on Option Care Health from $41.00 to $34.00 and set a “buy” rating for the company in a report on Friday, November 1st. UBS Group began coverage on shares of Option Care Health in a research report on Thursday, December 5th. They set a “neutral” rating and a $26.00 price objective on the stock. The Goldman Sachs Group lowered shares of Option Care Health from a “buy” rating to a “neutral” rating and dropped their price objective for the company from $38.00 to $27.00 in a research note on Monday, November 4th. JMP Securities reiterated a “market outperform” rating and set a $30.00 target price (down previously from $31.00) on shares of Option Care Health in a research note on Friday, January 10th. Finally, Bank of America upgraded Option Care Health from a “neutral” rating to a “buy” rating and boosted their price target for the company from $26.00 to $33.00 in a research report on Monday, January 13th. Two investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $32.25.

Option Care Health Stock Up 1.1 %

Option Care Health stock opened at $30.33 on Thursday. The stock has a 50-day simple moving average of $24.42 and a 200-day simple moving average of $27.82. The company has a market capitalization of $5.16 billion, a P/E ratio of 25.49, a PEG ratio of 2.11 and a beta of 1.31. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. Option Care Health has a fifty-two week low of $21.39 and a fifty-two week high of $34.63.

Insider Activity at Option Care Health

In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. acquired 43,000 shares of the company’s stock in a transaction that occurred on Friday, November 8th. The shares were purchased at an average price of $22.54 per share, with a total value of $969,220.00. Following the completion of the acquisition, the director now directly owns 326,334 shares of the company’s stock, valued at approximately $7,355,568.36. The trade was a 15.18 % increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this hyperlink. 0.64% of the stock is owned by insiders.

Institutional Investors Weigh In On Option Care Health

Institutional investors have recently made changes to their positions in the stock. Jennison Associates LLC lifted its stake in shares of Option Care Health by 4.5% in the fourth quarter. Jennison Associates LLC now owns 493,363 shares of the company’s stock valued at $11,446,000 after purchasing an additional 21,089 shares during the period. Highland Capital Management LLC acquired a new stake in shares of Option Care Health during the 4th quarter valued at approximately $238,000. Pacer Advisors Inc. boosted its stake in shares of Option Care Health by 2.2% during the 4th quarter. Pacer Advisors Inc. now owns 25,483 shares of the company’s stock worth $591,000 after acquiring an additional 537 shares in the last quarter. KBC Group NV grew its holdings in shares of Option Care Health by 46.4% in the 4th quarter. KBC Group NV now owns 7,337 shares of the company’s stock worth $170,000 after acquiring an additional 2,324 shares during the period. Finally, Blue Trust Inc. increased its stake in Option Care Health by 16.9% in the 4th quarter. Blue Trust Inc. now owns 4,703 shares of the company’s stock valued at $109,000 after purchasing an additional 681 shares in the last quarter. 98.05% of the stock is currently owned by hedge funds and other institutional investors.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.